TOLI

Natholiani “Toli” was diagnosed with T cell acute lymphoblastic leukemia October 8, 2017 . We have been hospitalized three times. His body has responded well so far, yet is currently battling Neurotoxicity from nelarabine drug. He hasn’t had any seizures in 2 days. He is 4 chemo days and two lumbar punctures away from stepping into maintenance stage. He will be done in February 2021.  Complications he’s faced have been: 3 hospitalizations, an allergic reaction to platelets and one blood transfusion reaction, an ammonia liver, seizures, and tremors with neurological side effects with changes in his EEG and MRI in his frontal left lobe of his brain.